Kevin T. Conroy - Feb 10, 2023 Form 4 Insider Report for EXACT SCIENCES CORP (EXAS)

Role
President and CEO, Director
Signature
/s/ Kevin T. Conroy by Mark R. Busch, attorney-in-fact
Stock symbol
EXAS
Transactions as of
Feb 10, 2023
Transactions value $
-$292,218
Form type
4
Date filed
2/14/2023, 04:40 PM
Previous filing
Aug 16, 2022
Next filing
Feb 16, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EXAS Common Stock Options Exercise $0 +9.71K +0.83% $0.00 1.18M Feb 10, 2023 Direct F1
transaction EXAS Common Stock Sale -$292K -4.53K -0.38% $64.55 1.17M Feb 13, 2023 Direct F2, F3
holding EXAS Common Stock 27.1K Feb 10, 2023 Held in 401(k) Plan
holding EXAS Common Stock 21.7K Feb 10, 2023 Held in Grantor Retained Annuity Trust
holding EXAS Common Stock 21.7K Feb 10, 2023 Held in Grantor Retained Annuity Trust
holding EXAS Common Stock 21.7K Feb 10, 2023 Held in Grantor Retained Annuity Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EXAS Performance Stock Units Options Exercise $0 -9.71K -100% $0.00* 0 Feb 10, 2023 Common Stock 9.71K Direct F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock received upon settlement of a performance share unit award (the "PSU Award") on February 10, 2023, which is described further in Footnote 5 to this Form 4.
F2 Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain performance stock units on February 10, 2023.
F3 In addition to the shares of Common Stock reported on this Form 4, which total 1,265,393 shares, Mr. Conroy also holds, in the aggregate, an additional 761,440 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock.
F4 Each Performance Share Unit represents a right to receive one share of common stock.
F5 On February 22, 2022, Mr. Conroy agreed to accept performance vesting stock units ("PSUs") in lieu of one-half of his bonus opportunity for 2022. The amount of the PSUs that ultimately vested was equal to the percentage of the bonus opportunity that was paid to bonus plan participants based on the achievement of corporate goals established for such plan.